D-0312-2025 Class III Ongoing
FDA drug recall D-0312-2025 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Mar 4, 2025 and is designated Class III. Reason for recall: Cross Contamination The recall status is ongoing. Affected quantity: 852 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 16, 2025
- Initiation Date
- Mar 4, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 852 bottles
Product description
Gabapentin Capsules, USP 400 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-139-05; b) 1000-count bottles, NDC 62756-139-04; Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.
Reason for recall
Cross Contamination
Distribution pattern
Nationwide in the USA
Code information
Lot # a) HAD1712B, Exp. date 03/2025 b) HAD1712C, exp. date 03/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0312-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026